FORESEE PHARMACEUTICALS CO., LTD.
Ownership & governance
Executives 5Directors 9Avg age 67Avg tenure 9.7y
BC
Benjamin Chien
Chief Executive Officer
Since 2013-02-07Profile →
+13
Executives5
Board of directors9
CY
Chang Jen Yan→
Director/Board Member
—Since 2013-01-09
SY
Sheng Lee Yi→
Director/Board Member
—Since 2013-01-09
GL
George Lee→
Director/Board Member
Age 75Since 2015-08-02
CW
Chia Lin Wang→
Director/Board Member
—Since 2016-03-30
KL
Kun Hung Lai→
Director/Board Member
—Since 2018-06-25
WL
Wen Chi Lee→
Director/Board Member
—Since 2016-03-30
FY
Fu Shiow Yin→
Director/Board Member
—Since 2016-03-30
BC
Benjamin Chien→
Chairman
—Since 2013-02-07
Catalog · 2026-07-09
Registry officers14
| Name | Role | Since | Shares |
|---|---|---|---|
| Bassem Elmankabadi | Chief Tech/Sci/R&D Officer | 2023-04-16 | - |
| Benjamin Chien | Chairman | 2013-02-07 | - |
| Benjamin Chien | Chief Executive Officer | 2013-02-07 | - |
| Max Chan | Director of Finance/CFO | 2019-10-06 | - |
| Wenjin Yang | Chief Tech/Sci/R&D Officer | 2015-09-20 | - |
| Yu Hua Li | Chief Tech/Sci/R&D Officer | 2015-07-08 | - |
| Ben Liu | Director/Board Member | 2023-05-31 | - |
| Chang Jen Yan | Director/Board Member | 2013-01-09 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 153Range 153–153Analysts 1
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.